Table 3.
Amoxicillin | Placebo | Interaction terma (95% CI) | P-value | Odds ratio for subgroupa (95% CI) | P-value | |
---|---|---|---|---|---|---|
Whole cohort | 162/1021 | 194/1006 | 0.79 (0.63 to 0.99) | 0.043 | ||
Green sputum | 40/221 | 43/185 | 0.93 (0.53 to 1.61) | 0.787 | 0.73 (0.45 to 1.18) | 0.202 |
Current smoker | 47/304 | 45/269 | 1.21 (0.72 to 2.03) | 0.482 | 0.91 (0.58,1.42) | 0.680 |
Significant past historyb | 44/257 | 47/243 | 1.11 (0.65 to 1.88) | 0.692 | 0.86 (0.55 to 1.36) | 0.520 |
Prior duration of illness >7 days | 70/411 | 74/390 | 1.16 (0.73 to 1.86) | 0.528 | 0.88 (0.61 to 1.26) | 0.474 |
Fever at baseline | 59/345 | 70/347 | 1.05 (0.65 to 1.69) | 0.844 | 0.82 (0.56 to 1.20) | 0.300 |
Minor chest signs | 57/345 | 70/334 | 0.92 (0.57 to 1.49) | 0.740 | 0.75 (0.51 to 1.10) | 0.139 |
Estimates controlled for baseline symptom severity.
Lung disease, heart disease, diabetes, or hospital admission.